Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lumidigm is a biometrics technology company specializing in multispectral imaging for high-performance fingerprint authentication. The company's proprietary technology captures fingerprint data from both the surface and the subsurface of the skin, providing reliable identity verification even in challenging conditions such as wet, dry, or dirty fingers. In the healthcare sector, Lumidigm's sensors are utilized for patient identity management to ensure accurate record-keeping, prevent medical identity theft, and enhance patient safety by reducing clinical errors. The company's solutions are also widely used in the banking, government, and enterprise security sectors. Lumidigm was acquired by HID Global in 2014 and its technology is now integrated into HID's broader secure identity portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lumidigm.